Difference between revisions of "Part:BBa K4361300"
Line 3: | Line 3: | ||
<partinfo>BBa_K4361300 short</partinfo> | <partinfo>BBa_K4361300 short</partinfo> | ||
− | A mutant of the BlcR protein, created through site-directed mutagenesis with primers R1 ([[Part:BBa_K4361200]]) and F1.1 D37R ([[Part:BBa_K4361201]]). For this mutant, the aspartic acid in position 37 has been changed to arginine by mutating the GAC codon to CGC. | + | A mutant of the BlcR protein ([[Part:BBa_K4361100]]), created through site-directed mutagenesis with primers R1 ([[Part:BBa_K4361200]]) and F1.1 D37R ([[Part:BBa_K4361201]]). For this mutant, the aspartic acid in position 37 has been changed to arginine by mutating the GAC codon to CGC. |
This mutant also contains the following nucleotide mutations outside of the targeted site: | This mutant also contains the following nucleotide mutations outside of the targeted site: | ||
Line 20: | Line 20: | ||
<html> | <html> | ||
<h3>Usage and Biology</h3> | <h3>Usage and Biology</h3> | ||
− | The set of BlcR mutants (this part through </html>[[Part:BBa_K4361319]]<html>) were | + | The set of BlcR mutants (this part through </html>[[Part:BBa_K4361319]]<html>) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (<b>Figure 1.</b>) to determine whether or not the protein was produced. For this mutant (<u>lane 1</u>), it was concluded that the production was not succesful due to the bands corresponding to BlcR being too poorly distinguishable. |
<figure> | <figure> | ||
− | <a href="https://static.igem.wiki/teams/4361/wiki/results/ | + | <a href="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure-1.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure-1.png" style="width:600px;margin-left:125px"></a> |
<figcaption> <b>Figure 1.</b> SDS PAGE gel of PURE reactions with GreenLys and a variant of </html>[[Part:BBa_K4361106]]<html> containing a BlcR mutant. Arrows indicate bands corresponding to BlcR dimers and monomers, respectively. C = negative control, WT = wildtype BlcR.</figcaption> | <figcaption> <b>Figure 1.</b> SDS PAGE gel of PURE reactions with GreenLys and a variant of </html>[[Part:BBa_K4361106]]<html> containing a BlcR mutant. Arrows indicate bands corresponding to BlcR dimers and monomers, respectively. C = negative control, WT = wildtype BlcR.</figcaption> | ||
</figure> | </figure> |
Revision as of 12:33, 11 October 2022
BlcR D37R
A mutant of the BlcR protein (Part:BBa_K4361100), created through site-directed mutagenesis with primers R1 (Part:BBa_K4361200) and F1.1 D37R (Part:BBa_K4361201). For this mutant, the aspartic acid in position 37 has been changed to arginine by mutating the GAC codon to CGC.
This mutant also contains the following nucleotide mutations outside of the targeted site:
- G 763 > A, resulting in substitution E255K
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 694
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 78
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 589
Usage and Biology
The set of BlcR mutants (this part through Part:BBa_K4361319) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (Figure 1.) to determine whether or not the protein was produced. For this mutant (lane 1), it was concluded that the production was not succesful due to the bands corresponding to BlcR being too poorly distinguishable.